Sutro Biopharma
STRO
134 hedge funds and large institutions have $855M invested in Sutro Biopharma in 2020 Q4 according to their latest regulatory filings, with 61 funds opening new positions, 45 increasing their positions, 18 reducing their positions, and 13 closing their positions.
369% more first-time investments, than exits
New positions opened: 61 | Existing positions closed: 13
200% more funds holding in top 10
Funds holding in top 10: 2 → 6 (+4)
179% more capital invested
Capital invested by funds: $307M → $855M (+$548M)
150% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 18
96% more call options, than puts
Call options by funds: $1.5M | Put options by funds: $763K
56% more funds holding
Funds holding: 86 → 134 (+48)
0.14% more ownership
Funds ownership: 8.51% → 8.66% (+0.14%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$36.9M |
| 2 |
Holocene Advisors
New York
|
+$17.7M |
| 3 |
FM
Frazier Management
Seattle,
Washington
|
+$16.6M |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$13.7M |
| 5 |
BlackRock
New York
|
+$11.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$50M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$20.4M |
| 3 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$6.03M |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$4.8M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$4.14M |
STRO Hedge Fund Activity: Q4 2020 in Review
134 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Sutro Biopharma (STRO) for Q4 2020, worth a combined $855M — up 179% from $307M a quarter earlier.
Buyers outnumbered sellers: 61 funds opened new STRO positions and 13 closed out — a net gain of 48 holders — while 45 added to existing stakes and 18 trimmed.
The largest buyer was Franklin Resources, opening a new position worth an estimated $36.9M. The largest seller was EcoR1 Capital, cutting an estimated $50M.
- 134 institutional investors held Sutro Biopharma (STRO) as of Q4 2020, up from 86 in Q3 2020.
- Funds reported $855M of Sutro Biopharma stock for Q4 2020, up 179% quarter-over-quarter.
- 61 funds opened new Sutro Biopharma positions in Q4 2020 and 13 closed out, a net change of +48 holders.
- The largest Sutro Biopharma buyer in Q4 2020 was Franklin Resources, an estimated $36.9M added.
- The largest Sutro Biopharma seller in Q4 2020 was EcoR1 Capital, an estimated $50M sold.
Based on aggregated 13F filings for Q4 2020.